Transcriptomics

Dataset Information

0

The Role of Mechanoregulated YAP/TAZ in Erectile Dysfunction


ABSTRACT: Phosphodiesterase type 5 inhibitors (PDE5is) are the primary therapeutic option for erectile dysfunction. However, 30% of patients do not respond to PDE5is treatment, making the quest for a new treatment modality a central endeavor. Here, we found a new pathway in erectile function control, mechano-regulated YAP/TAZ activate Adrenomedullin transcription, which sustains smooth muscle cells (SMCs) relaxation to maintain the erection. We first found that penile erection stretches the SMCs, dominating YAP/TAZ activity. Subsequently, we showed that YAP/TAZ plays a vital role in erectile function and penile rehabilitation using genetic lesions and several animal models. The mechanism relies on the regulation of Adrenomedullin on penile SMCs contraction, which we identify here as a direct YAP/TAZ transcript. Notably, conventional PDE5is targeting NO-cGMP signaling do not cure YAP/TAZ deficient ED. In contrast, by activating YAP/TAZ-Adrenomedullin cascade, mechano-stimulation improved erectile function, including PDE5is non-responders in both experimental models and clinical trials. Our studies lay the groundwork for exploring mechano-YAP/TAZ-Adrenomedullin as prospective targets in the treatment of ED

ORGANISM(S): Mus musculus Rattus norvegicus

PROVIDER: GSE208293 | GEO | 2023/03/31

REPOSITORIES: GEO

Similar Datasets

2012-12-31 | E-GEOD-31247 | biostudies-arrayexpress
2012-12-31 | GSE31247 | GEO
2022-07-13 | GSE183220 | GEO
2022-05-11 | GSE180916 | GEO
2023-03-10 | MSV000091464 | MassIVE
2022-12-07 | GSE168545 | GEO
2021-07-07 | GSE146500 | GEO
2016-06-06 | GSE79115 | GEO
2022-06-23 | GSE206528 | GEO
2017-06-13 | PXD005751 | Pride